Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Vaccines

  Free Subscription


Articles published in J Gen Virol

Retrieve available abstracts of 37 articles:
HTML format



Single Articles


    April 2021
  1. CHOI JA, Wu K, Kim GN, Saeedian N, et al
    Induction of protective immune responses against a lethal Zika virus challenge post-vaccination with a dual serotype of recombinant vesicular stomatitis virus carrying the genetically modified Zika virus E protein gene.
    J Gen Virol. 2021;102.
    PubMed     Abstract available


    March 2021
  2. CHOI KY, El-Hamdi NS, McGregor A
    A trimeric capable gB CMV vaccine provides limited protection against a highly cell associated and epithelial tropic strain of cytomegalovirus in guinea pigs.
    J Gen Virol. 2021 Mar 17. doi: 10.1099/jgv.0.001579.
    PubMed     Abstract available


  3. RESLAN L, Mishra N, Finianos M, Zakka K, et al
    The origins of G12P[6] rotavirus strains detected in Lebanon.
    J Gen Virol. 2021;102.
    PubMed     Abstract available


    September 2020
  4. TIAN D, Subramaniam S, Heffron CL, Mahsoub HM, et al
    Construction and efficacy evaluation of novel swine leukocyte antigen (SLA) class I and class II allele-specific poly-T cell epitope vaccines against porcine reproductive and respiratory syndrome virus.
    J Gen Virol. 2020 Sep 7. doi: 10.1099/jgv.0.001492.
    PubMed     Abstract available


    June 2020
  5. MUNYANDUKI H, Douglass N, Offerman K, Carulei O, et al
    Influence of the lumpy skin disease virus (LSDV) superoxide dismutase homologue on host transcriptional activity, apoptosis and histopathology.
    J Gen Virol. 2020;101:645-650.
    PubMed     Abstract available


    April 2020
  6. LAWLER C, Stevenson PG
    Limited protection against gamma-herpesvirus infection by replication-deficient virus particles.
    J Gen Virol. 2020;101:420-425.
    PubMed     Abstract available


    March 2020
  7. MURR M, Karger A, Steglich C, Mettenleiter TC, et al
    Coexpression of soluble and membrane-bound avian influenza virus H5 by recombinant Newcastle disease virus leads to an increase in antigen levels.
    J Gen Virol. 2020 Mar 25. doi: 10.1099/jgv.0.001405.
    PubMed     Abstract available


  8. KIM T, Spatz SJ, Dunn JR
    Vaccinal efficacy of molecularly cloned Gallid alphaherpesvirus 3 strain 301B/1 against very virulent Marek's disease virus challenge.
    J Gen Virol. 2020 Mar 5. doi: 10.1099/jgv.0.001403.
    PubMed     Abstract available


    February 2020
  9. NEIDEL S, Torres AA, Ren H, Smith GL, et al
    Leaky scanning translation generates a second A49 protein that contributes to vaccinia virus virulence.
    J Gen Virol. 2020 Feb 25. doi: 10.1099/jgv.0.001386.
    PubMed     Abstract available


  10. CHOI KY, El-Hamdi NS, McGregor A
    Requirements for guinea pig cytomegalovirus tropism and antibody neutralization on placental amniotic sac cells.
    J Gen Virol. 2020 Feb 18. doi: 10.1099/jgv.0.001394.
    PubMed     Abstract available


    November 2019
  11. SLON-CAMPOS JL, Poggianella M, Zentilin L, Burrone OR, et al
    Use of Adeno-associated viral vectors to improve delivery of a DNA vaccine against dengue virus.
    J Gen Virol. 2019 Nov 8. doi: 10.1099/jgv.0.001351.
    PubMed     Abstract available


    July 2019
  12. PEI J, Huang F, Wu Q, Luo Z, et al
    Codon optimization of G protein enhances rabies virus-induced humoral immunity.
    J Gen Virol. 2019 Jul 1. doi: 10.1099/jgv.0.001299.
    PubMed     Abstract available


    June 2019
  13. DEFORD DM, Nosek JM, Castiglia KR, Hasik EF, et al
    Evaluation of the role of respiratory syncytial virus surface glycoproteins F and G on viral stability and replication: implications for future vaccine design.
    J Gen Virol. 2019 Jun 11. doi: 10.1099/jgv.0.001287.
    PubMed     Abstract available


  14. HUSSAIN S, Turnbull ML, Pinto RM, McCauley JW, et al
    Segment 2 from influenza A(H1N1) 2009 pandemic viruses confers temperature-sensitive haemagglutinin yield on candidate vaccine virus growth in eggs that can be epistatically complemented by PB2 701D.
    J Gen Virol. 2019 Jun 6. doi: 10.1099/jgv.0.001279.
    PubMed     Abstract available


    May 2019
  15. SCHADLER J, Sigrist B, Meier SM, Albini S, et al
    Virus-like particles in a new vaccination approach against infectious laryngotracheitis.
    J Gen Virol. 2019 May 17. doi: 10.1099/jgv.0.001272.
    PubMed     Abstract available


  16. VALDES I, Izquierdo A, Cobas K, Thao P, et al
    A heterologous prime-boost strategy for immunization against Dengue virus combining the Tetra DIIIC subunit vaccine candidate with the TV005 live-attenuated tetravalent vaccine.
    J Gen Virol. 2019 May 15. doi: 10.1099/jgv.0.001271.
    PubMed     Abstract available


    April 2019
  17. CHEN C, Zhou M, Yan XG, Chen YX, et al
    A recombinant canine distemper virus expressing interleukin-7 enhances humoral immunity.
    J Gen Virol. 2019;100:602-615.
    PubMed     Abstract available


    March 2019
  18. KOOPMAN G, Mortier D, Michels S, Hofman S, et al
    Influenza virus infection as well as immunization with DNA encoding haemagglutinin protein induces potent antibody-dependent phagocytosis (ADP) and monocyte infection-enhancing responses in macaques.
    J Gen Virol. 2019 Mar 28. doi: 10.1099/jgv.0.001251.
    PubMed     Abstract available


    February 2019
  19. POWELL TJ, Rijal P, McEwen-Smith RM, Byun H, et al
    A single cycle influenza virus coated in H7 haemagglutinin generates neutralizing antibody responses to haemagglutinin and neuraminidase glycoproteins and protection from heterotypic challenge.
    J Gen Virol. 2019 Feb 4. doi: 10.1099/jgv.0.001228.
    PubMed     Abstract available


    October 2018
  20. LI J, Hou G, Wang Y, Wang S, et al
    Protective efficacy of an inactivated chimeric H5 avian influenza vaccine against H5 highly pathogenic avian influenza virus clades 2.3.4.4 and 2.3.2.1.
    J Gen Virol. 2018 Oct 25. doi: 10.1099/jgv.0.001140.
    PubMed     Abstract available


  21. BICKERTON E, Dowgier G, Britton P
    Recombinant infectious bronchitis viruses expressing heterologous S1 subunits: potential for a new generation of vaccines that replicate in Vero cells.
    J Gen Virol. 2018 Oct 24. doi: 10.1099/jgv.0.001167.
    PubMed     Abstract available


    September 2018
  22. SCHRODER L, Klafack S, Bergmann SM, Fichtner D, et al
    Generation of a potential koi herpesvirus live vaccine by simultaneous deletion of the viral thymidine kinase and dUTPase genes.
    J Gen Virol. 2018 Sep 19. doi: 10.1099/jgv.0.001148.
    PubMed     Abstract available


    July 2018
  23. LOCHER S, Schweneker M, Hausmann J, Zimmer G, et al
    Immunogenicity of propagation-restricted vesicular stomatitis virus encoding Ebola virus glycoprotein in guinea pigs.
    J Gen Virol. 2018;99:866-879.
    PubMed     Abstract available


    June 2018
  24. SLON CAMPOS JL, Poggianella M, Burrone OR
    Long-term stability of antibody responses elicited by Dengue virus envelope DIII-based DNA vaccines.
    J Gen Virol. 2018 Jun 20. doi: 10.1099/jgv.0.001094.
    PubMed     Abstract available


  25. NEROME K, Yamaguchi R, Fuke N, Izzati UZ, et al
    Development of a Japanese encephalitis virus genotype V virus-like particle vaccine in silkworms.
    J Gen Virol. 2018 Jun 7. doi: 10.1099/jgv.0.001081.
    PubMed     Abstract available


    April 2018
  26. LUTEIJN RD, Drexler I, Smith GL, Lebbink RJ, et al
    Mutagenic repair of double-stranded DNA breaks in vaccinia virus genomes requires cellular DNA ligase IV activity in the cytosol.
    J Gen Virol. 2018 Apr 20. doi: 10.1099/jgv.0.001034.
    PubMed     Abstract available


    February 2018
  27. BISWAS S, Smith GL, Roy EJ, Ward B, et al
    A comparison of the effect of molluscum contagiosum virus MC159 and MC160 proteins on vaccinia virus virulence in intranasal and intradermal infection routes.
    J Gen Virol. 2018;99:246-252.
    PubMed     Abstract available


    January 2018
  28. SUBRAMANIAM S, Yugo DM, Heffron CL, Rogers AJ, et al
    Vaccination of sows with a dendritic cell-targeted porcine epidemic diarrhea virus S1 protein-based candidate vaccine reduced viral shedding but exacerbated gross pathological lesions in suckling neonatal piglets.
    J Gen Virol. 2018 Jan 4. doi: 10.1099/jgv.0.001001.
    PubMed     Abstract available


  29. EVANS JS, Selden D, Wu G, Wright E, et al
    Antigenic site changes in the rabies virus glycoprotein dictates functionality and neutralizing capability against divergent lyssaviruses.
    J Gen Virol. 2018 Jan 4. doi: 10.1099/jgv.0.000998.
    PubMed     Abstract available


    November 2017
  30. YU Q, Liu Y, Du J, Liu Y, et al
    Porcine circovirus type 1 was undetected in vaccine but could be cultured in the cell substrate of Lanzhou lamb rotavirus vaccine.
    J Gen Virol. 2017 Nov 22. doi: 10.1099/jgv.0.000875.
    PubMed     Abstract available


  31. MOI ML, Ami Y, Muhammad Azami NA, Shirai K, et al
    Marmosets (Callithrix jacchus) as a non-human primate model for evaluation of candidate dengue vaccines: induction and maintenance of specific protective immunity against challenges with clinical isolates.
    J Gen Virol. 2017 Nov 21. doi: 10.1099/jgv.0.000913.
    PubMed     Abstract available


  32. DUFFY MR, Alonso-Padilla J, John L, Chandra N, et al
    Generation and characterization of a novel candidate gene therapy and vaccination vector based on human species D adenovirus type 56.
    J Gen Virol. 2017 Nov 20. doi: 10.1099/jgv.0.000978.
    PubMed     Abstract available


  33. TIAN D, Sooryanarain H, Matzinger SR, Gauger PC, et al
    Protective efficacy of a virus-vectored multi-component vaccine against porcine reproductive and respiratory syndrome virus, porcine circovirus type 2 and swine influenza virus.
    J Gen Virol. 2017 Nov 1. doi: 10.1099/jgv.0.000964.
    PubMed     Abstract available


    October 2017
  34. MALUQUER DE MOTES C, Smith GL
    Vaccinia virus protein A49 activates Wnt signalling by targetting the E3 ligase beta-TrCP.
    J Gen Virol. 2017 Oct 17. doi: 10.1099/jgv.0.000946.
    PubMed     Abstract available


  35. SEHATA G, Sato H, Yamanaka M, Takahashi T, et al
    Substitutions at residues 300 and 389 of the VP2 capsid protein serve as the minimal determinant of attenuation for canine parvovirus vaccine strain 9985-46.
    J Gen Virol. 2017 Oct 6. doi: 10.1099/jgv.0.000936.
    PubMed     Abstract available


    September 2017
  36. CARPENTIER DCJ, Hollinshead MS, Ewles HA, Lee SA, et al
    Tagging of the vaccinia virus protein F13 with mCherry causes aberrant virion morphogenesis.
    J Gen Virol. 2017 Sep 20. doi: 10.1099/jgv.0.000917.
    PubMed     Abstract available


    July 2017
  37. KANDEIL A, Kayed A, Moatasim Y, Webby RJ, et al
    Genetic characterization of highly pathogenic avian influenza A H5N8 viruses isolated from wild birds in Egypt.
    J Gen Virol. 2017 Jul 18. doi: 10.1099/jgv.0.000847.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Vaccines is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: